Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

Presentation TCT 2025

TCT 519: Sirolimus eluting balloon efficacy and safety. A prospective registry of large vs small vessels

Presenter: Marco Ferrone

October 28, 2025

Presentation TCT 2025

TCT 517: Safety and efficacy of sirolimus-coated drug balloons for percutaneous coronary interventions in a real-world cohort: Results from the Selution-SIROOP registry

Presenter: Matthias Bossard

October 27, 2025

Presentation TCT 2025

TCT 512: Outcomes of the PREVAIL DCB Study: Efficacy and Safety of Drug-Coated Balloons in Complex Coronary Lesions

Presenter: Davit Baghdasaryan

October 27, 2025

Presentation TCT 2025

First Clinical Experience with Solaris Drug-Eluting (DE) Covered Stent: Primary Endpoint Report of the DEScover Randomized Multicenter Trial on the Safety and Efficacy of Solaris DE in Hemodialysis Patients with AV Fistula and Graft Outflow Stenosis

Presenter: Leonardo de Oliveira Harduin

October 26, 2025

Presentation TCT 2025

Durable Safety and Efficacy of Renal Denervation using the Symplicity Spyral Catheter in Patients Taking Antihypertensive Drugs: Final, 3-Year Results from the SPYRAL HTN-ON MED Randomized Study

Presenter: David E. Kandzari

October 26, 2025

Presentation TCT 2025

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

Presenter: Seung-Whan Lee

October 26, 2025

Presentation TCT 2024

TCT 315: Acute and Long-Term Safety and Efficacy of IVUS-Guided Drug Coated Balloon Treatment for Carotid In-Stent Restenosis

Presenter: Piero Montorsi

October 29, 2024

Presentation TCT 2024

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Presenter: David Kandzari

October 28, 2024

Presentation TCT 2023

Patient-Level Meta-analysis on PTX Safety

Presenter: William Gray

October 24, 2023

Presentation TCT 2023

Real World Evidence About PTX Safety

Presenter: Eric Secemsky

October 24, 2023

Presentation TCT 2022

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

Presenter: Bruno Scheller

September 18, 2022

Presentation TCT 2022

TCT 26: Efficacy and Safety of Ticagrelor Compared to Clopidogrel in Elderly Patients With ST-Elevation Myocardial Infarction

Presenter: André Luz

September 17, 2022

Presentation TCT 2020

VOYAGER PAD: Long-term Safety of Drug-Coated Devices in Peripheral Artery Revascularization

Presenter: Connie N. Hess

October 18, 2020

Presentation TCT 2020

VOYAGER PAD: Long-term Safety of Drug-Coated Devices in Peripheral Artery Revascularization

Presenter: Connie Hess

October 18, 2020

Presentation TCT 2019

The Absorb BVS Epilogue: How Did We Miss the Safety Signals?

Presenter: Renu Virmani

September 28, 2019

Presentation TCT 2019

Long-Term Safety of Drug-Coated Devices for Femoropopliteal Artery Revascularization: Updated Analysis of Medicare Beneficiary Data

Presenter: Eric Secemsky

September 27, 2019

Presentation TCT 2019

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Presenter: Ian Meredith AM

September 26, 2019

Presentation TCT 2019

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Presenter: Elazer Edelman

September 26, 2019

Presentation TCT 2018

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Antonio L. Bartorelli, David G. Rizik, Michael Haude

September 21, 2018

Presentation TCT 2017

DCB Architecture: Technical Features Determining Long-term Safety and Efficacy

Presenter: William A. Gray, Thomas Zeller, Juan F. Granada

November 01, 2017

Advertisement

TCT 519: Sirolimus eluting balloon efficacy and safety. A prospective registry of large vs small vessels

TCT 517: Safety and efficacy of sirolimus-coated drug balloons for percutaneous coronary interventions in a real-world cohort: Results from the Selution-SIROOP registry

TCT 512: Outcomes of the PREVAIL DCB Study: Efficacy and Safety of Drug-Coated Balloons in Complex Coronary Lesions

First Clinical Experience with Solaris Drug-Eluting (DE) Covered Stent: Primary Endpoint Report of the DEScover Randomized Multicenter Trial on the Safety and Efficacy of Solaris DE in Hemodialysis Patients with AV Fistula and Graft Outflow Stenosis

Durable Safety and Efficacy of Renal Denervation using the Symplicity Spyral Catheter in Patients Taking Antihypertensive Drugs: Final, 3-Year Results from the SPYRAL HTN-ON MED Randomized Study

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

TCT 315: Acute and Long-Term Safety and Efficacy of IVUS-Guided Drug Coated Balloon Treatment for Carotid In-Stent Restenosis

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Patient-Level Meta-analysis on PTX Safety

Real World Evidence About PTX Safety

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

TCT 26: Efficacy and Safety of Ticagrelor Compared to Clopidogrel in Elderly Patients With ST-Elevation Myocardial Infarction

VOYAGER PAD: Long-term Safety of Drug-Coated Devices in Peripheral Artery Revascularization

VOYAGER PAD: Long-term Safety of Drug-Coated Devices in Peripheral Artery Revascularization

The Absorb BVS Epilogue: How Did We Miss the Safety Signals?

Long-Term Safety of Drug-Coated Devices for Femoropopliteal Artery Revascularization: Updated Analysis of Medicare Beneficiary Data

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

DCB Architecture: Technical Features Determining Long-term Safety and Efficacy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content